

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of skin barrier (GO:0061436) | 9.47209568 |
| 2 | regulation of water loss via skin (GO:0033561) | 8.87491724 |
| 3 | negative regulation of keratinocyte proliferation (GO:0010839) | 7.73239814 |
| 4 | keratinocyte proliferation (GO:0043616) | 7.20527223 |
| 5 | keratinocyte differentiation (GO:0030216) | 6.99772372 |
| 6 | gap junction assembly (GO:0016264) | 6.38134441 |
| 7 | regulation of keratinocyte proliferation (GO:0010837) | 6.06680306 |
| 8 | multicellular organismal water homeostasis (GO:0050891) | 6.03001944 |
| 9 | intermediate filament organization (GO:0045109) | 5.97142535 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.94260685 |
| 11 | L-phenylalanine catabolic process (GO:0006559) | 5.94260685 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.78052929 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 5.78052929 |
| 14 | epidermal cell differentiation (GO:0009913) | 5.72887969 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.67483346 |
| 16 | molting cycle (GO:0042303) | 5.65393265 |
| 17 | hair cycle (GO:0042633) | 5.65393265 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 5.29667198 |
| 19 | epidermis development (GO:0008544) | 5.29594140 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.16106928 |
| 21 | peptide cross-linking (GO:0018149) | 5.03121396 |
| 22 | water homeostasis (GO:0030104) | 5.02967250 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.98447192 |
| 24 | kynurenine metabolic process (GO:0070189) | 4.96882001 |
| 25 | urea metabolic process (GO:0019627) | 4.95406263 |
| 26 | urea cycle (GO:0000050) | 4.95406263 |
| 27 | intestinal epithelial cell development (GO:0060576) | 4.95405874 |
| 28 | indole-containing compound catabolic process (GO:0042436) | 4.79594501 |
| 29 | indolalkylamine catabolic process (GO:0046218) | 4.79594501 |
| 30 | tryptophan catabolic process (GO:0006569) | 4.79594501 |
| 31 | glyoxylate metabolic process (GO:0046487) | 4.69263813 |
| 32 | intestinal cholesterol absorption (GO:0030299) | 4.65012039 |
| 33 | alpha-linolenic acid metabolic process (GO:0036109) | 4.64569817 |
| 34 | cysteine metabolic process (GO:0006534) | 4.64365012 |
| 35 | bile acid biosynthetic process (GO:0006699) | 4.61832668 |
| 36 | bile acid and bile salt transport (GO:0015721) | 4.57601494 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.57283444 |
| 38 | keratinocyte development (GO:0003334) | 4.55651410 |
| 39 | tryptophan metabolic process (GO:0006568) | 4.54894393 |
| 40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.53828175 |
| 41 | protein carboxylation (GO:0018214) | 4.53828175 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.51284713 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.50621939 |
| 44 | nitrogen cycle metabolic process (GO:0071941) | 4.49559720 |
| 45 | negative regulation of fibrinolysis (GO:0051918) | 4.45480081 |
| 46 | cellular glucuronidation (GO:0052695) | 4.42358020 |
| 47 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.40570992 |
| 48 | phospholipid efflux (GO:0033700) | 4.40391714 |
| 49 | regulation of protein activation cascade (GO:2000257) | 4.40052279 |
| 50 | bile acid metabolic process (GO:0008206) | 4.38383429 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.38169903 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.33576212 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 4.33576212 |
| 54 | macromolecular complex remodeling (GO:0034367) | 4.33576212 |
| 55 | lysine metabolic process (GO:0006553) | 4.31969317 |
| 56 | lysine catabolic process (GO:0006554) | 4.31969317 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.28629689 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.28629689 |
| 59 | intestinal absorption (GO:0050892) | 4.27574877 |
| 60 | ectoderm development (GO:0007398) | 4.26536768 |
| 61 | intermediate filament cytoskeleton organization (GO:0045104) | 4.25052843 |
| 62 | complement activation, alternative pathway (GO:0006957) | 4.24756501 |
| 63 | regulation of fibrinolysis (GO:0051917) | 4.23558910 |
| 64 | amino-acid betaine metabolic process (GO:0006577) | 4.22417888 |
| 65 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.19761674 |
| 66 | cell-substrate junction assembly (GO:0007044) | 4.15702096 |
| 67 | flavonoid metabolic process (GO:0009812) | 4.15293792 |
| 68 | surfactant homeostasis (GO:0043129) | 4.14911282 |
| 69 | regulation of complement activation (GO:0030449) | 4.12573388 |
| 70 | drug catabolic process (GO:0042737) | 4.11714987 |
| 71 | acylglycerol homeostasis (GO:0055090) | 4.09765238 |
| 72 | triglyceride homeostasis (GO:0070328) | 4.09765238 |
| 73 | regulation of bile acid biosynthetic process (GO:0070857) | 4.09207502 |
| 74 | intermediate filament-based process (GO:0045103) | 4.08302325 |
| 75 | serine family amino acid catabolic process (GO:0009071) | 3.99642491 |
| 76 | phospholipid homeostasis (GO:0055091) | 3.99360668 |
| 77 | glucuronate metabolic process (GO:0019585) | 3.96299760 |
| 78 | uronic acid metabolic process (GO:0006063) | 3.96299760 |
| 79 | regulation of cardioblast differentiation (GO:0051890) | 3.94970018 |
| 80 | cellular ketone body metabolic process (GO:0046950) | 3.94472196 |
| 81 | cholesterol efflux (GO:0033344) | 3.93167144 |
| 82 | plasma lipoprotein particle assembly (GO:0034377) | 3.93102906 |
| 83 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.91704876 |
| 84 | * bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.88121525 |
| 85 | ethanol oxidation (GO:0006069) | 3.87999722 |
| 86 | aromatic amino acid family metabolic process (GO:0009072) | 3.87330537 |
| 87 | regulation of cholesterol homeostasis (GO:2000188) | 3.83898512 |
| 88 | plasma lipoprotein particle clearance (GO:0034381) | 3.83549553 |
| 89 | polarized epithelial cell differentiation (GO:0030859) | 3.80137717 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.77006612 |
| 91 | lipoprotein metabolic process (GO:0042157) | 3.75799682 |
| 92 | chemical homeostasis within a tissue (GO:0048875) | 3.73791754 |
| 93 | tyrosine metabolic process (GO:0006570) | 3.72756490 |
| 94 | alpha-amino acid catabolic process (GO:1901606) | 3.72566345 |
| 95 | sterol homeostasis (GO:0055092) | 3.72264882 |
| 96 | establishment of planar polarity (GO:0001736) | 3.69380239 |
| 97 | establishment of tissue polarity (GO:0007164) | 3.69380239 |
| 98 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.67215644 |
| 99 | benzene-containing compound metabolic process (GO:0042537) | 3.64047226 |
| 100 | skin morphogenesis (GO:0043589) | 3.63162214 |
| 101 | protein-lipid complex assembly (GO:0065005) | 3.59908344 |
| 102 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59779940 |
| 103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59779940 |
| 104 | * ventricular cardiac muscle cell action potential (GO:0086005) | 3.58359166 |
| 105 | positive regulation of epidermis development (GO:0045684) | 3.57918111 |
| 106 | cellular amino acid catabolic process (GO:0009063) | 3.52563009 |
| 107 | response to nitrosative stress (GO:0051409) | 3.51792740 |
| 108 | negative regulation of lipase activity (GO:0060192) | 3.47531140 |
| 109 | positive regulation of lipid catabolic process (GO:0050996) | 3.45595792 |
| 110 | cellular modified amino acid catabolic process (GO:0042219) | 3.43267293 |
| 111 | glutamate metabolic process (GO:0006536) | 3.43138916 |
| 112 | sphingosine metabolic process (GO:0006670) | 3.42208200 |
| 113 | ketone body metabolic process (GO:1902224) | 3.41292761 |
| 114 | regulation of hair follicle development (GO:0051797) | 3.41172548 |
| 115 | regulation of keratinocyte differentiation (GO:0045616) | 3.39518050 |
| 116 | plasma lipoprotein particle organization (GO:0071827) | 3.38632330 |
| 117 | low-density lipoprotein particle remodeling (GO:0034374) | 3.37686405 |
| 118 | ethanol metabolic process (GO:0006067) | 3.36733250 |
| 119 | short-chain fatty acid metabolic process (GO:0046459) | 3.36657419 |
| 120 | carnitine metabolic process (GO:0009437) | 3.36110945 |
| 121 | arginine metabolic process (GO:0006525) | 3.35232976 |
| 122 | fatty acid oxidation (GO:0019395) | 3.35023619 |
| 123 | indolalkylamine metabolic process (GO:0006586) | 3.34947926 |
| 124 | fatty acid beta-oxidation (GO:0006635) | 3.34581136 |
| 125 | drug metabolic process (GO:0017144) | 3.33931002 |
| 126 | xenobiotic catabolic process (GO:0042178) | 3.32719096 |
| 127 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.31773678 |
| 128 | fibrinolysis (GO:0042730) | 3.30926941 |
| 129 | imidazole-containing compound metabolic process (GO:0052803) | 3.30699012 |
| 130 | lipid oxidation (GO:0034440) | 3.27293021 |
| 131 | glycine metabolic process (GO:0006544) | 3.25823098 |
| 132 | lateral sprouting from an epithelium (GO:0060601) | 3.24553808 |
| 133 | exogenous drug catabolic process (GO:0042738) | 3.22916003 |
| 134 | protein-lipid complex subunit organization (GO:0071825) | 3.22872299 |
| 135 | 2-oxoglutarate metabolic process (GO:0006103) | 3.22798233 |
| 136 | serine family amino acid metabolic process (GO:0009069) | 3.22248215 |
| 137 | organic acid catabolic process (GO:0016054) | 3.21837556 |
| 138 | sphingoid metabolic process (GO:0046519) | 3.21141636 |
| 139 | negative regulation of epidermis development (GO:0045683) | 3.18128033 |
| 140 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.16463423 |
| 141 | regulation of transforming growth factor beta production (GO:0071634) | 3.16363533 |
| 142 | diol metabolic process (GO:0034311) | 3.13142132 |
| 143 | auditory receptor cell differentiation (GO:0042491) | 3.12583125 |
| 144 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.11741248 |
| 145 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.11733536 |
| 146 | tight junction assembly (GO:0070830) | 3.10899116 |
| 147 | regulation of epidermis development (GO:0045682) | 3.07407499 |
| 148 | epithelial cell-cell adhesion (GO:0090136) | 3.07297529 |
| 149 | cell-cell junction assembly (GO:0007043) | 3.01137233 |
| 150 | genitalia morphogenesis (GO:0035112) | 2.98665905 |
| 151 | negative regulation of cell fate specification (GO:0009996) | 2.96883620 |
| 152 | regulation of hair cycle (GO:0042634) | 2.95909418 |
| 153 | hair cell differentiation (GO:0035315) | 2.92833497 |
| 154 | * regulation of heart rate by cardiac conduction (GO:0086091) | 2.91859483 |
| 155 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.86355789 |
| 156 | cellular component disassembly involved in execution phase of apoptosis (GO:0006921) | 2.84010295 |
| 157 | sulfate transmembrane transport (GO:1902358) | 2.80073393 |
| 158 | detection of bacterium (GO:0016045) | 2.79701002 |
| 159 | epithelium development (GO:0060429) | 2.78349882 |
| 160 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.76609735 |
| 161 | * cell communication involved in cardiac conduction (GO:0086065) | 2.74778877 |
| 162 | detection of other organism (GO:0098543) | 2.73385771 |
| 163 | angiotensin maturation (GO:0002003) | 2.73282285 |
| 164 | regulation of epidermal cell differentiation (GO:0045604) | 2.72834282 |
| 165 | notochord development (GO:0030903) | 2.69007755 |
| 166 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.68800936 |
| 167 | protein autoprocessing (GO:0016540) | 2.67959029 |
| 168 | O-glycan processing (GO:0016266) | 2.66334119 |
| 169 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.65204744 |
| 170 | renal filtration (GO:0097205) | 2.62898167 |
| 171 | cell junction assembly (GO:0034329) | 2.62572141 |
| 172 | vitamin A metabolic process (GO:0006776) | 2.62481506 |
| 173 | trophectodermal cell differentiation (GO:0001829) | 2.62102936 |
| 174 | mesodermal cell differentiation (GO:0048333) | 2.60556314 |
| 175 | sequestering of metal ion (GO:0051238) | 2.59006029 |
| 176 | cell junction organization (GO:0034330) | 2.57704497 |
| 177 | transcytosis (GO:0045056) | 2.54897942 |
| 178 | atrioventricular valve morphogenesis (GO:0003181) | 2.54242512 |
| 179 | sphingomyelin metabolic process (GO:0006684) | 2.52301724 |
| 180 | linoleic acid metabolic process (GO:0043651) | 2.50055459 |
| 181 | cell adhesion mediated by integrin (GO:0033627) | 2.49912990 |
| 182 | hair follicle morphogenesis (GO:0031069) | 2.47143671 |
| 183 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.45960274 |
| 184 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.43796600 |
| 185 | cardiac right ventricle morphogenesis (GO:0003215) | 2.43454210 |
| 186 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.43363786 |
| 187 | skin development (GO:0043588) | 2.39481265 |
| 188 | lipoxygenase pathway (GO:0019372) | 2.38492441 |
| 189 | renal system process involved in regulation of blood volume (GO:0001977) | 2.37921171 |
| 190 | desmosome organization (GO:0002934) | 13.0415631 |
| 191 | hemidesmosome assembly (GO:0031581) | 12.2003765 |
| 192 | keratinization (GO:0031424) | 10.1466539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.24697302 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.69868305 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.01686546 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.48366734 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.16653389 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.64019700 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.41191317 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.07766431 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.62822304 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.57882028 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.53864802 |
| 12 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.39923017 |
| 13 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.31325078 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.28836250 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.14020373 |
| 16 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.01974416 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90320841 |
| 18 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.89697506 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.85164155 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76241664 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75282222 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.73655976 |
| 23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.70673817 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.69326536 |
| 25 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.68959945 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.68487004 |
| 27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.68309008 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.65293068 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59621206 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.54625105 |
| 31 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.50577539 |
| 32 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.48635879 |
| 33 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.41510989 |
| 34 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38633625 |
| 35 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.36923879 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.33514790 |
| 37 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.31909396 |
| 38 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.31591325 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31181346 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30446716 |
| 41 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.27710885 |
| 42 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.23193051 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19740618 |
| 44 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.18634576 |
| 45 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17188095 |
| 46 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16623691 |
| 47 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14972628 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13868140 |
| 49 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13859748 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10410598 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10223575 |
| 52 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09584638 |
| 53 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09304597 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08530036 |
| 55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.08199552 |
| 56 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08197273 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07482826 |
| 58 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06595533 |
| 59 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04958181 |
| 60 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.04778949 |
| 61 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03911156 |
| 62 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03030533 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02006418 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01404125 |
| 65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00872777 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98710624 |
| 67 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97653676 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95955210 |
| 69 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95633233 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94442079 |
| 71 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93987218 |
| 72 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93623976 |
| 73 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91991771 |
| 74 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91479764 |
| 75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.91176704 |
| 76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90440710 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90440710 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90147774 |
| 79 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88042079 |
| 80 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87213107 |
| 81 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87193366 |
| 82 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86903543 |
| 83 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86504613 |
| 84 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86486448 |
| 85 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86416965 |
| 86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84906054 |
| 87 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.84402554 |
| 88 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.84055603 |
| 89 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83678782 |
| 90 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83199616 |
| 91 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83199616 |
| 92 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82075001 |
| 93 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81749452 |
| 94 | ATF3_27146783_Chip-Seq_COLON_Human | 0.81316452 |
| 95 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.80966199 |
| 96 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.80458280 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.80254485 |
| 98 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79404856 |
| 99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79404856 |
| 100 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.78538317 |
| 101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77911136 |
| 102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77603314 |
| 103 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77505604 |
| 104 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.76850231 |
| 105 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.76794107 |
| 106 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.75933622 |
| 107 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75361397 |
| 108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.75313915 |
| 109 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.75292165 |
| 110 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.74536826 |
| 111 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.73953914 |
| 112 | TP53_16413492_ChIP-PET_HCT116_Human | 0.73451347 |
| 113 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.73251815 |
| 114 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.72695486 |
| 115 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.71151546 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71063932 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70867284 |
| 118 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.70332735 |
| 119 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.69665861 |
| 120 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.69243040 |
| 121 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.69073766 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.68980381 |
| 123 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.67567686 |
| 124 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.67006512 |
| 125 | CJUN_26792858_Chip-Seq_BT549_Human | 0.66782830 |
| 126 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.65981220 |
| 127 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63064797 |
| 128 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.62341078 |
| 129 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.61771998 |
| 130 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.60944191 |
| 131 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60367372 |
| 132 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.59525081 |
| 133 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58104774 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.56834964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.94220515 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.75300351 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.79908135 |
| 4 | MP0005365_abnormal_bile_salt | 5.34518964 |
| 5 | MP0003941_abnormal_skin_development | 4.57473753 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.55764115 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.74158653 |
| 8 | MP0003252_abnormal_bile_duct | 3.67066282 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.41460287 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.15606854 |
| 11 | MP0009840_abnormal_foam_cell | 2.89619885 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.81666817 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.79148858 |
| 14 | MP0005409_darkened_coat_color | 2.59846753 |
| 15 | MP0005083_abnormal_biliary_tract | 2.58163381 |
| 16 | MP0002254_reproductive_system_inflammat | 2.56966461 |
| 17 | MP0000762_abnormal_tongue_morphology | 2.42339214 |
| 18 | MP0005332_abnormal_amino_acid | 2.22720216 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.11196592 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 2.06388427 |
| 21 | MP0010771_integument_phenotype | 2.02973227 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 1.91496242 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.86178380 |
| 24 | MP0003195_calcinosis | 1.85837444 |
| 25 | MP0000609_abnormal_liver_physiology | 1.85580735 |
| 26 | MP0004381_abnormal_hair_follicle | 1.80363067 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.74216385 |
| 28 | MP0003868_abnormal_feces_composition | 1.66396599 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.64338968 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.62976315 |
| 31 | MP0003890_abnormal_embryonic-extraembry | 1.48783372 |
| 32 | MP0003878_abnormal_ear_physiology | 1.35966061 |
| 33 | MP0005377_hearing/vestibular/ear_phenot | 1.35966061 |
| 34 | MP0002796_impaired_skin_barrier | 1.34708491 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.32276196 |
| 36 | MP0003315_abnormal_perineum_morphology | 1.31495082 |
| 37 | MP0004885_abnormal_endolymph | 1.29999205 |
| 38 | MP0000579_abnormal_nail_morphology | 1.29122469 |
| 39 | MP0005451_abnormal_body_composition | 1.26935024 |
| 40 | MP0009931_abnormal_skin_appearance | 1.25866297 |
| 41 | MP0001191_abnormal_skin_condition | 1.18225253 |
| 42 | MP0009697_abnormal_copulation | 1.16996981 |
| 43 | MP0009053_abnormal_anal_canal | 1.14428909 |
| 44 | MP0002234_abnormal_pharynx_morphology | 1.12413461 |
| 45 | MP0008004_abnormal_stomach_pH | 1.12252561 |
| 46 | MP0000647_abnormal_sebaceous_gland | 1.12114041 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.10766020 |
| 48 | MP0000367_abnormal_coat/_hair | 1.09806620 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09627970 |
| 50 | MP0001764_abnormal_homeostasis | 1.04572833 |
| 51 | MP0002098_abnormal_vibrissa_morphology | 1.03583585 |
| 52 | MP0003011_delayed_dark_adaptation | 1.02163825 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.00545550 |
| 54 | MP0010678_abnormal_skin_adnexa | 0.99691621 |
| 55 | MP0000462_abnormal_digestive_system | 0.98295950 |
| 56 | MP0000627_abnormal_mammary_gland | 0.98000820 |
| 57 | MP0000598_abnormal_liver_morphology | 0.95121244 |
| 58 | MP0002837_dystrophic_cardiac_calcinosis | 0.94120129 |
| 59 | MP0009384_cardiac_valve_regurgitation | 0.93983839 |
| 60 | MP0000467_abnormal_esophagus_morphology | 0.92176233 |
| 61 | MP0003186_abnormal_redox_activity | 0.90162646 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 0.86609462 |
| 63 | MP0000678_abnormal_parathyroid_gland | 0.84885969 |
| 64 | MP0003300_gastrointestinal_ulcer | 0.83168159 |
| 65 | MP0002060_abnormal_skin_morphology | 0.82842564 |
| 66 | MP0010368_abnormal_lymphatic_system | 0.82429399 |
| 67 | MP0000537_abnormal_urethra_morphology | 0.80949336 |
| 68 | MP0005408_hypopigmentation | 0.80610395 |
| 69 | MP0009764_decreased_sensitivity_to | 0.78900261 |
| 70 | MP0001873_stomach_inflammation | 0.77687550 |
| 71 | MP0000538_abnormal_urinary_bladder | 0.76650855 |
| 72 | MP0005248_abnormal_Harderian_gland | 0.74759387 |
| 73 | MP0006054_spinal_hemorrhage | 0.74132821 |
| 74 | MP0001851_eye_inflammation | 0.73088101 |
| 75 | MP0009642_abnormal_blood_homeostasis | 0.71165982 |
| 76 | MP0001188_hyperpigmentation | 0.70434116 |
| 77 | MP0002111_abnormal_tail_morphology | 0.69744448 |
| 78 | MP0009763_increased_sensitivity_to | 0.69028591 |
| 79 | MP0000604_amyloidosis | 0.68503558 |
| 80 | MP0003045_fibrosis | 0.66479617 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.66299312 |
| 82 | MP0004957_abnormal_blastocyst_morpholog | 0.66183456 |
| 83 | MP0002697_abnormal_eye_size | 0.65920068 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 0.65864097 |
| 85 | MP0005084_abnormal_gallbladder_morpholo | 0.65628111 |
| 86 | MP0001216_abnormal_epidermal_layer | 0.65416179 |
| 87 | MP0005220_abnormal_exocrine_pancreas | 0.65041901 |
| 88 | MP0003566_abnormal_cell_adhesion | 0.64618216 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.64168361 |
| 90 | MP0001849_ear_inflammation | 0.63651966 |
| 91 | MP0005647_abnormal_sex_gland | 0.63532390 |
| 92 | MP0002009_preneoplasia | 0.63508398 |
| 93 | MP0005023_abnormal_wound_healing | 0.63338191 |
| 94 | MP0004130_abnormal_muscle_cell | 0.62889998 |
| 95 | MP0001663_abnormal_digestive_system | 0.62587126 |
| 96 | MP0008260_abnormal_autophagy | 0.62441786 |
| 97 | MP0005330_cardiomyopathy | 0.62341916 |
| 98 | MP0001756_abnormal_urination | 0.62251360 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.62174752 |
| 100 | MP0005275_abnormal_skin_tensile | 0.62164609 |
| 101 | MP0005266_abnormal_metabolism | 0.62101967 |
| 102 | MP0005381_digestive/alimentary_phenotyp | 0.62034917 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.61442985 |
| 104 | MP0010155_abnormal_intestine_physiology | 0.61298944 |
| 105 | MP0000566_synostosis | 0.61276531 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.60931341 |
| 107 | MP0003755_abnormal_palate_morphology | 0.60909443 |
| 108 | MP0005501_abnormal_skin_physiology | 0.60318730 |
| 109 | MP0000377_abnormal_hair_follicle | 0.60210806 |
| 110 | MP0000383_abnormal_hair_follicle | 0.59596543 |
| 111 | MP0001664_abnormal_digestion | 0.58700926 |
| 112 | MP0008469_abnormal_protein_level | 0.58650541 |
| 113 | MP0005257_abnormal_intraocular_pressure | 0.57404095 |
| 114 | MP0002006_tumorigenesis | 0.57318126 |
| 115 | MP0002282_abnormal_trachea_morphology | 0.57270551 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.57088862 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.55944076 |
| 118 | MP0000477_abnormal_intestine_morphology | 0.55740873 |
| 119 | MP0000427_abnormal_hair_cycle | 0.55711319 |
| 120 | MP0005448_abnormal_energy_balance | 0.54395496 |
| 121 | MP0000470_abnormal_stomach_morphology | 0.54113293 |
| 122 | MP0006036_abnormal_mitochondrial_physio | 0.53454549 |
| 123 | MP0000490_abnormal_crypts_of | 0.53162018 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.52382807 |
| 125 | MP0005076_abnormal_cell_differentiation | 0.52374559 |
| 126 | MP0001346_abnormal_lacrimal_gland | 0.52282084 |
| 127 | MP0003937_abnormal_limbs/digits/tail_de | 0.52035489 |
| 128 | MP0002136_abnormal_kidney_physiology | 0.51993225 |
| 129 | MP0002086_abnormal_extraembryonic_tissu | 0.51992084 |
| 130 | MP0004043_abnormal_pH_regulation | 0.51826650 |
| 131 | MP0000432_abnormal_head_morphology | 0.51356635 |
| 132 | MP0005187_abnormal_penis_morphology | 0.50458529 |
| 133 | MP0001784_abnormal_fluid_regulation | 0.49789063 |
| 134 | MP0004272_abnormal_basement_membrane | 0.49371537 |
| 135 | MP0001881_abnormal_mammary_gland | 0.49026301 |
| 136 | MP0000613_abnormal_salivary_gland | 0.48758894 |
| 137 | MP0009765_abnormal_xenobiotic_induced | 0.48469827 |
| 138 | MP0005334_abnormal_fat_pad | 0.48247334 |
| 139 | MP0004947_skin_inflammation | 0.48085859 |
| 140 | MP0002971_abnormal_brown_adipose | 0.47756374 |
| 141 | MP0006138_congestive_heart_failure | 0.46519740 |
| 142 | MP0005165_increased_susceptibility_to | 0.46454193 |
| 143 | MP0004197_abnormal_fetal_growth/weight/ | 0.45959464 |
| 144 | MP0003638_abnormal_response/metabolism_ | 0.44699501 |
| 145 | MP0002166_altered_tumor_susceptibility | 0.42416541 |
| 146 | MP0001485_abnormal_pinna_reflex | 0.42098127 |
| 147 | MP0003119_abnormal_digestive_system | 0.41826307 |
| 148 | MP0002084_abnormal_developmental_patter | 0.40888384 |
| 149 | MP0002896_abnormal_bone_mineralization | 0.39867041 |
| 150 | MP0003693_abnormal_embryo_hatching | 0.39635142 |
| 151 | MP0002233_abnormal_nose_morphology | 0.37571727 |
| 152 | MP0009780_abnormal_chondrocyte_physiolo | 0.37532465 |
| 153 | MP0003936_abnormal_reproductive_system | 0.36684676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Palmoplantar hyperkeratosis (HP:0000972) | 6.82509858 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.73733553 |
| 3 | Palmar hyperkeratosis (HP:0010765) | 6.54391967 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.07622331 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.05460063 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.01355649 |
| 7 | Thick nail (HP:0001805) | 5.77607625 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.69698006 |
| 9 | Xanthomatosis (HP:0000991) | 5.46007672 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.96536455 |
| 11 | Abnormality of the axillary hair (HP:0100134) | 4.70163220 |
| 12 | Abnormality of secondary sexual hair (HP:0009888) | 4.70163220 |
| 13 | Oral leukoplakia (HP:0002745) | 4.65764404 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.64495369 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.63768214 |
| 16 | Pili torti (HP:0003777) | 4.43601750 |
| 17 | Hypotrichosis (HP:0001006) | 4.33950362 |
| 18 | * Right ventricular cardiomyopathy (HP:0011663) | 4.29613845 |
| 19 | Hypoglycemic coma (HP:0001325) | 4.28861204 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 4.26648376 |
| 21 | Hyperammonemia (HP:0001987) | 4.25310080 |
| 22 | Nail dystrophy (HP:0008404) | 4.23453671 |
| 23 | Fat malabsorption (HP:0002630) | 4.18088430 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.15488739 |
| 25 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.12834908 |
| 26 | Epidermoid cyst (HP:0200040) | 4.12436171 |
| 27 | Atrophic scars (HP:0001075) | 4.05763124 |
| 28 | Complement deficiency (HP:0004431) | 4.00852373 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.98996204 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.97838944 |
| 31 | Erythroderma (HP:0001019) | 3.79560142 |
| 32 | Corneal erosion (HP:0200020) | 3.72478026 |
| 33 | Hyperglycinuria (HP:0003108) | 3.72320785 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.69446409 |
| 35 | Sparse eyelashes (HP:0000653) | 3.66607312 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.63712637 |
| 37 | * Woolly hair (HP:0002224) | 3.63619697 |
| 38 | Ketosis (HP:0001946) | 3.62541548 |
| 39 | Abnormal hair laboratory examination (HP:0003328) | 3.59056476 |
| 40 | Abnormal blistering of the skin (HP:0008066) | 3.55910692 |
| 41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.53706751 |
| 42 | Lip pit (HP:0100267) | 3.43811335 |
| 43 | Absent eyelashes (HP:0000561) | 3.40538575 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.40271335 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 3.40271335 |
| 46 | Ectropion (HP:0000656) | 3.35864423 |
| 47 | Hypercholesterolemia (HP:0003124) | 3.33134929 |
| 48 | Hyperglycinemia (HP:0002154) | 3.32665734 |
| 49 | Abnormality of the intrinsic pathway (HP:0010989) | 3.30345800 |
| 50 | Ridged nail (HP:0001807) | 3.28946465 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28011887 |
| 52 | Joint hemorrhage (HP:0005261) | 3.27257136 |
| 53 | Hypoplastic labia majora (HP:0000059) | 3.16843406 |
| 54 | Abnormality of methionine metabolism (HP:0010901) | 3.16324793 |
| 55 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.13493213 |
| 56 | Malnutrition (HP:0004395) | 3.06772505 |
| 57 | Ketoacidosis (HP:0001993) | 3.06177408 |
| 58 | * Palmoplantar keratoderma (HP:0000982) | 3.05295718 |
| 59 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.03740322 |
| 60 | Increased IgE level (HP:0003212) | 2.99445448 |
| 61 | Abnormality of the salivary glands (HP:0010286) | 2.98363030 |
| 62 | Sparse scalp hair (HP:0002209) | 2.96753780 |
| 63 | Hypoplasia of dental enamel (HP:0006297) | 2.96451305 |
| 64 | Hyperbilirubinemia (HP:0002904) | 2.96348022 |
| 65 | Abnormality of complement system (HP:0005339) | 2.91430239 |
| 66 | Abnormality of proline metabolism (HP:0010907) | 2.91244782 |
| 67 | Hydroxyprolinuria (HP:0003080) | 2.91244782 |
| 68 | Amelogenesis imperfecta (HP:0000705) | 2.91157151 |
| 69 | Ileus (HP:0002595) | 2.89341006 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.83333547 |
| 71 | Abnormality of the labia majora (HP:0012881) | 2.82164489 |
| 72 | Abnormality of nucleobase metabolism (HP:0010932) | 2.81129567 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 2.80385667 |
| 74 | Esophageal varix (HP:0002040) | 2.79744484 |
| 75 | Acanthocytosis (HP:0001927) | 2.78659865 |
| 76 | Absent hair (HP:0002298) | 2.78100742 |
| 77 | Parakeratosis (HP:0001036) | 2.77029575 |
| 78 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.76721607 |
| 79 | Blepharitis (HP:0000498) | 2.76643828 |
| 80 | Steatorrhea (HP:0002570) | 2.74624501 |
| 81 | Natal tooth (HP:0000695) | 2.71323597 |
| 82 | Vascular calcification (HP:0004934) | 2.70208993 |
| 83 | Hypohidrosis (HP:0000966) | 2.68167380 |
| 84 | Erythema (HP:0010783) | 2.66907561 |
| 85 | Hypoglycemic seizures (HP:0002173) | 2.63763140 |
| 86 | Metabolic acidosis (HP:0001942) | 2.63429406 |
| 87 | Skin nodule (HP:0200036) | 2.61915203 |
| 88 | Pterygium (HP:0001059) | 2.61644578 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 2.58868901 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.58868901 |
| 91 | Amniotic constriction ring (HP:0009775) | 2.56644405 |
| 92 | Abnormality of placental membranes (HP:0011409) | 2.56644405 |
| 93 | Dehydration (HP:0001944) | 2.51077767 |
| 94 | Advanced eruption of teeth (HP:0006288) | 2.48899456 |
| 95 | Curly hair (HP:0002212) | 2.44694798 |
| 96 | Popliteal pterygium (HP:0009756) | 2.44661433 |
| 97 | Myocardial infarction (HP:0001658) | 2.43593189 |
| 98 | Lethargy (HP:0001254) | 2.42651060 |
| 99 | Cardiovascular calcification (HP:0011915) | 2.42086448 |
| 100 | Selective tooth agenesis (HP:0001592) | 2.42055524 |
| 101 | Hyperglycemia (HP:0003074) | 2.40939347 |
| 102 | Spontaneous abortion (HP:0005268) | 2.39948982 |
| 103 | Ventricular tachycardia (HP:0004756) | 2.39397528 |
| 104 | Hyperactive renin-angiotensin system (HP:0000841) | 2.37935175 |
| 105 | Onycholysis (HP:0001806) | 2.37327308 |
| 106 | Abnormal gallbladder morphology (HP:0012437) | 2.34404393 |
| 107 | Cholelithiasis (HP:0001081) | 2.32995494 |
| 108 | Late onset (HP:0003584) | 2.31755877 |
| 109 | Flat acetabular roof (HP:0003180) | 2.31429485 |
| 110 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.30580200 |
| 111 | Aplasia cutis congenita (HP:0001057) | 2.24763979 |
| 112 | Generalized aminoaciduria (HP:0002909) | 2.23495660 |
| 113 | Abnormal gallbladder physiology (HP:0012438) | 2.23033154 |
| 114 | Cholecystitis (HP:0001082) | 2.23033154 |
| 115 | Gout (HP:0001997) | 2.21653711 |
| 116 | Abnormality of serum amino acid levels (HP:0003112) | 2.21517011 |
| 117 | Anonychia (HP:0001798) | 2.20164594 |
| 118 | Spastic diplegia (HP:0001264) | 2.18850907 |
| 119 | Delayed CNS myelination (HP:0002188) | 2.17598692 |
| 120 | Dry hair (HP:0011359) | 2.17471857 |
| 121 | Labial hypoplasia (HP:0000066) | 2.17114513 |
| 122 | Laryngomalacia (HP:0001601) | 2.12276540 |
| 123 | Carious teeth (HP:0000670) | 2.11904370 |
| 124 | Cerebral edema (HP:0002181) | 2.10736277 |
| 125 | Abnormal cartilage morphology (HP:0002763) | 2.07349156 |
| 126 | Abnormality of the gastric mucosa (HP:0004295) | 2.06939388 |
| 127 | Pancreatitis (HP:0001733) | 2.06264250 |
| 128 | Ankyloglossia (HP:0010296) | 2.06017770 |
| 129 | Glycosuria (HP:0003076) | 2.03457112 |
| 130 | Abnormality of urine glucose concentration (HP:0011016) | 2.03457112 |
| 131 | Hypochromic microcytic anemia (HP:0004840) | 2.00743821 |
| 132 | Abnormality of vitamin metabolism (HP:0100508) | 2.00487798 |
| 133 | Systemic lupus erythematosus (HP:0002725) | 2.00476848 |
| 134 | Abdominal distention (HP:0003270) | 2.00334999 |
| 135 | Abnormality of nail color (HP:0100643) | 10.0644224 |
| 136 | Alopecia of scalp (HP:0002293) | 1.98744240 |
| 137 | Hemorrhage of the eye (HP:0011885) | 1.98677566 |
| 138 | Hypoplastic female external genitalia (HP:0012815) | 1.98440394 |
| 139 | Follicular hyperkeratosis (HP:0007502) | 1.97733660 |
| 140 | Symptomatic seizures (HP:0011145) | 1.97299028 |
| 141 | Plantar hyperkeratosis (HP:0007556) | 1.95915830 |
| 142 | Poikilocytosis (HP:0004447) | 1.95599733 |
| 143 | Myoglobinuria (HP:0002913) | 1.92136959 |
| 144 | Proximal tubulopathy (HP:0000114) | 1.90912697 |
| 145 | Irritability (HP:0000737) | 1.90460934 |
| 146 | Oligodontia (HP:0000677) | 1.89189350 |
| 147 | Vomiting (HP:0002013) | 1.88881724 |
| 148 | Increased purine levels (HP:0004368) | 1.88402013 |
| 149 | Hyperuricemia (HP:0002149) | 1.88402013 |
| 150 | Sensorimotor neuropathy (HP:0007141) | 1.87200918 |
| 151 | Milia (HP:0001056) | 1.86929322 |
| 152 | Fragile skin (HP:0001030) | 1.85906486 |
| 153 | Pustule (HP:0200039) | 1.84619011 |
| 154 | Abnormality of permanent molar morphology (HP:0011071) | 1.84008082 |
| 155 | Abnormality of the dental root (HP:0006486) | 1.84008082 |
| 156 | Taurodontia (HP:0000679) | 1.84008082 |
| 157 | Abnormality of the gallbladder (HP:0005264) | 1.83991880 |
| 158 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82262317 |
| 159 | Hyperhidrosis (HP:0000975) | 1.81672143 |
| 160 | Pigmentary retinal degeneration (HP:0001146) | 1.81429550 |
| 161 | Renal cortical cysts (HP:0000803) | 1.81064373 |
| 162 | Fragile nails (HP:0001808) | 1.81043784 |
| 163 | Esophageal atresia (HP:0002032) | 1.80624349 |
| 164 | Glomerulonephritis (HP:0000099) | 1.79902288 |
| 165 | Furrowed tongue (HP:0000221) | 1.76967330 |
| 166 | Neonatal onset (HP:0003623) | 1.76557752 |
| 167 | Autoamputation (HP:0001218) | 1.76308573 |
| 168 | Pruritus (HP:0000989) | 1.73507753 |
| 169 | Abnormality of the dental pulp (HP:0006479) | 1.66409901 |
| 170 | Villous atrophy (HP:0011473) | 1.65702915 |
| 171 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.65702915 |
| 172 | Septate vagina (HP:0001153) | 1.64668974 |
| 173 | Abnormality of the fingernails (HP:0001231) | 1.64647257 |
| 174 | Abnormality of molar morphology (HP:0011070) | 1.64236228 |
| 175 | Abnormality of molar (HP:0011077) | 1.64236228 |
| 176 | Gangrene (HP:0100758) | 1.64000374 |
| 177 | Cheilitis (HP:0100825) | 1.62071143 |
| 178 | Premature loss of primary teeth (HP:0006323) | 1.61569653 |
| 179 | Neonatal death (HP:0003811) | 1.58462154 |
| 180 | Xerostomia (HP:0000217) | 1.57838486 |
| 181 | Abnormality of hair growth rate (HP:0011363) | 1.56866405 |
| 182 | Slow-growing hair (HP:0002217) | 1.56866405 |
| 183 | Abnormal tarsal ossification (HP:0008369) | 1.55631945 |
| 184 | Multifactorial inheritance (HP:0001426) | 1.54865874 |
| 185 | Skin pits (HP:0100276) | 1.54668540 |
| 186 | Abnormality of chloride homeostasis (HP:0011422) | 1.54458061 |
| 187 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.52866706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.50905564 |
| 2 | BCKDK | 3.82069792 |
| 3 | ACVR1B | 3.50227726 |
| 4 | MST1R | 3.28366878 |
| 5 | ERN1 | 3.05855155 |
| 6 | LMTK2 | 3.01803720 |
| 7 | EPHA2 | 2.82823822 |
| 8 | LATS1 | 2.78065556 |
| 9 | ERBB4 | 2.64968914 |
| 10 | PKN2 | 2.63283727 |
| 11 | FGFR4 | 2.60023086 |
| 12 | SIK1 | 2.57802566 |
| 13 | PTK6 | 2.33736357 |
| 14 | INSRR | 2.14783874 |
| 15 | LATS2 | 2.09829246 |
| 16 | TGFBR1 | 2.01110596 |
| 17 | CDK12 | 2.01015006 |
| 18 | MST4 | 1.96208300 |
| 19 | TRIB3 | 1.92042420 |
| 20 | RIPK1 | 1.82728565 |
| 21 | PIK3CA | 1.75904859 |
| 22 | STK38L | 1.71770479 |
| 23 | MAP2K2 | 1.71007215 |
| 24 | TAOK3 | 1.70446211 |
| 25 | MYLK | 1.67008723 |
| 26 | STK39 | 1.66475101 |
| 27 | MAP3K3 | 1.65301362 |
| 28 | MAP3K12 | 1.59224868 |
| 29 | MAP3K2 | 1.55534131 |
| 30 | EPHB2 | 1.54478036 |
| 31 | FER | 1.45027774 |
| 32 | NLK | 1.44377829 |
| 33 | PRKG2 | 1.41203273 |
| 34 | MET | 1.40724852 |
| 35 | TTN | 1.34124701 |
| 36 | PTK2 | 1.32579104 |
| 37 | PBK | 1.31836613 |
| 38 | ERBB2 | 1.25526946 |
| 39 | MAP3K10 | 1.23578675 |
| 40 | NUAK1 | 1.22102145 |
| 41 | MAP3K9 | 1.16405156 |
| 42 | MAP3K7 | 1.15692430 |
| 43 | FLT3 | 1.15400190 |
| 44 | BCR | 1.14649904 |
| 45 | EPHB1 | 1.14139344 |
| 46 | MAP3K6 | 1.14131790 |
| 47 | PIK3CG | 1.11597404 |
| 48 | MAPK11 | 1.10538958 |
| 49 | OXSR1 | 1.09208439 |
| 50 | NEK9 | 1.08206534 |
| 51 | OBSCN | 1.06614785 |
| 52 | ERBB3 | 1.06421405 |
| 53 | MAP2K1 | 1.05263074 |
| 54 | TYK2 | 1.04639563 |
| 55 | TNIK | 1.04321513 |
| 56 | PRKAA2 | 1.00931805 |
| 57 | CASK | 0.99816041 |
| 58 | PDK4 | 0.99648764 |
| 59 | PDK3 | 0.99648764 |
| 60 | CAMK1D | 0.98664999 |
| 61 | RPS6KB2 | 0.98614494 |
| 62 | CAMK1G | 0.93524441 |
| 63 | TRIM28 | 0.91511541 |
| 64 | MATK | 0.85451693 |
| 65 | PAK3 | 0.85320725 |
| 66 | WNK1 | 0.84999459 |
| 67 | EIF2AK3 | 0.83738594 |
| 68 | MAPK15 | 0.82182449 |
| 69 | STK38 | 0.81901485 |
| 70 | STK3 | 0.78851609 |
| 71 | BRD4 | 0.78317141 |
| 72 | GRK6 | 0.77228383 |
| 73 | YES1 | 0.76892665 |
| 74 | FGFR2 | 0.72395471 |
| 75 | AKT3 | 0.71112989 |
| 76 | TESK1 | 0.71064285 |
| 77 | MAP2K6 | 0.70778350 |
| 78 | MAP2K4 | 0.69768899 |
| 79 | PDK2 | 0.69540684 |
| 80 | EEF2K | 0.69528584 |
| 81 | CDK6 | 0.69507998 |
| 82 | EPHA3 | 0.68293739 |
| 83 | GRK1 | 0.66972970 |
| 84 | MAPKAPK3 | 0.66339534 |
| 85 | PDGFRA | 0.66278570 |
| 86 | NEK1 | 0.65391729 |
| 87 | JAK2 | 0.63753228 |
| 88 | CAMK2G | 0.62742139 |
| 89 | BMPR1B | 0.59460243 |
| 90 | FGR | 0.58447039 |
| 91 | DYRK1B | 0.57375002 |
| 92 | TBK1 | 0.56351501 |
| 93 | KDR | 0.56313502 |
| 94 | MAP2K3 | 0.55896538 |
| 95 | TRPM7 | 0.55042720 |
| 96 | PRKCE | 0.54779060 |
| 97 | SIK3 | 0.54294506 |
| 98 | PRKAA1 | 0.54085024 |
| 99 | NME1 | 0.52650505 |
| 100 | MAP3K1 | 0.52636671 |
| 101 | STK10 | 0.50923957 |
| 102 | MKNK1 | 0.50659783 |
| 103 | GSK3A | 0.50320594 |
| 104 | LRRK2 | 0.49912786 |
| 105 | KSR2 | 0.48113793 |
| 106 | BRSK2 | 0.47771191 |
| 107 | STK24 | 0.46730013 |
| 108 | DAPK2 | 0.46646484 |
| 109 | JAK1 | 0.46050472 |
| 110 | MAP3K11 | 0.45775941 |
| 111 | MKNK2 | 0.45690184 |
| 112 | MELK | 0.45002599 |
| 113 | CAMK2D | 0.43325351 |
| 114 | FGFR3 | 0.42835678 |
| 115 | ABL2 | 0.42509960 |
| 116 | RET | 0.42102633 |
| 117 | TGFBR2 | 0.41501159 |
| 118 | TAOK1 | 0.41463789 |
| 119 | PRKACG | 0.39625737 |
| 120 | PDGFRB | 0.39334607 |
| 121 | FGFR1 | 0.39220230 |
| 122 | PAK4 | 0.38563708 |
| 123 | TAF1 | 0.38390478 |
| 124 | PAK2 | 0.38083509 |
| 125 | TTK | 0.37995528 |
| 126 | PDPK1 | 0.37308014 |
| 127 | SGK223 | 0.36722279 |
| 128 | SGK494 | 0.36722279 |
| 129 | CSK | 0.36291307 |
| 130 | MAP3K8 | 0.36231203 |
| 131 | MTOR | 0.35912962 |
| 132 | IRAK1 | 0.35477961 |
| 133 | ROCK1 | 0.35335961 |
| 134 | DMPK | 0.35017466 |
| 135 | NTRK1 | 0.34595770 |
| 136 | CDC42BPA | 0.34126553 |
| 137 | PLK4 | 0.34065252 |
| 138 | PRKD1 | 0.33963418 |
| 139 | BMX | 0.33943541 |
| 140 | PRKCI | 0.32990272 |
| 141 | NEK6 | 0.32868958 |
| 142 | TIE1 | 0.32547908 |
| 143 | SGK3 | 0.29302012 |
| 144 | IGF1R | 0.23273389 |
| 145 | RPS6KA4 | 0.21900392 |
| 146 | DYRK3 | 0.20036502 |
| 147 | ARAF | 0.19404075 |
| 148 | RPS6KB1 | 0.19039894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.55378802 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41478445 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.20352111 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06830220 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.75484136 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64891674 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56652905 |
| 8 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.49991376 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.42337354 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32590109 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29865407 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.27973210 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27182357 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.19396701 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.18303874 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.16560829 |
| 17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.14381036 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.11481785 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.10741965 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.97135846 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94496666 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.92953279 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91938152 |
| 24 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.91872525 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87281001 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74533492 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74244098 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.72807049 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71679837 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.68053412 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67841262 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67640413 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.66938354 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.64815215 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.49689489 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.48048411 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44057607 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41418963 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41236852 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40727494 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37227099 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.34842177 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.32466642 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29544405 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28503616 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25498406 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.20003524 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19706520 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.18465051 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15856909 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15297009 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.13496048 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12413083 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10062413 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.09755293 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08126086 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.07519125 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04377903 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.04158739 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00288996 |
| 61 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.94397775 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88230960 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87830995 |
| 64 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.85045427 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84462630 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84312357 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82121084 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79913773 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79541878 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.76294532 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74702411 |
| 72 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.72896202 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.72303786 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71298639 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.71270790 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70598817 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.69276987 |
| 78 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.67090712 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66372103 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.63767364 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62842753 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61215795 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59420067 |
| 84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59032649 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58821198 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57837794 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.56947966 |
| 88 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55415405 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53805440 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51674581 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51322189 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49719338 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49217700 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47459541 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44040542 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42791421 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.42510368 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42407231 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40585630 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.39539820 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.38623002 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37742521 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35630496 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35010381 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34188308 |
| 106 | Phototransduction_Homo sapiens_hsa04744 | 0.32062351 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31822861 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31669557 |
| 109 | Axon guidance_Homo sapiens_hsa04360 | 0.30881675 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30494823 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30399739 |
| 112 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.27905499 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26442598 |
| 114 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.25322882 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21762612 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21286536 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18969716 |
| 118 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.18437958 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.14288996 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10755449 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.10577430 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08622019 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.07625329 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07179597 |
| 125 | Tight junction_Homo sapiens_hsa04530 | 0.07063120 |
| 126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.06915517 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.06748974 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.06259516 |
| 129 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.04760344 |
| 130 | Adherens junction_Homo sapiens_hsa04520 | 0.03813917 |
| 131 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.01647825 |
| 132 | Thyroid cancer_Homo sapiens_hsa05216 | -0.1099953 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0807352 |
| 134 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0480168 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0360535 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | -0.0285784 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0171339 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | -0.0030896 |

